Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2012 Jan;97(1):18-22.
doi: 10.1016/j.fertnstert.2011.11.036.

Should all women with PCOS be treated for insulin resistance?

John C Marshall  1 , Andrea Dunaif
Affiliations

Should all women with PCOS be treated for insulin resistance?

John C Marshall et al. Fertil Steril. 2012 Jan.

Abstract

PRO--A large majority of women with PCOS have insulin resistance, compensatory hyperinsulinemia with consequent reproductive and metabolic abnormalities. Metformin has been shown to be effective therapy and could be used more widely in obese adolescents with hyperandrogenemia, a forerunner of PCOS. CON--The severity of insulin resistance is highly variable in women with PCOS and may not be clinically relevant in milder phenotypes. Treatment should be directed at specific metabolic or reproductive problems and insulin sensitizing drugs are not always the optimum therapy.

PubMed Disclaimer

References

    1. Zawadski J, Dunaif A. Diagnostic criteria for polycystic ovary syndrome:towards a rational approach. In: Dunaif A, Givens J, Haseltine F, Merriam G, editors. Polycystic ovary syndrome. Oxford, UK: Blackwell Scientific; 1992. pp. 377–384.
    1. Azziz R, Carmina E, Dewailly D, Diamanti-Kandarakis E, Escobar-Morreale HF, Futterweit W, et al. Position statement: criteria for defining polycystic ovary syndrome as a predominantly hyperandrogenic syndrome: an Androgen Excess Society guideline. J Clin Endocrinol Metab. 2006;91:4237–4245. - PubMed
    1. DeUgarte CM, Barolucci AA, Azziz R. Prevalence of insulin resistance in the polycystic ovary syndrome using the homeostasis model assessment. Fertil Steril. 2005;83:1454–1460. - PubMed
    1. Mathur R, Alexander CJ, Yano J, Trivax B, Azziz R. Use of metformin in polycystic ovary syndrome. Am J Obstet Gynecol. 2008;199:596–609. - PubMed
    1. Ciaraldi TP, el-Roeiy A, Madar Z, Reichart D, Olefsky JM, Yen SS. Cellular mechanisms of insulin resistance in polycystic ovarian syndrome. J Clin Endocrinol Metab. 1992;75:577–583. - PubMed

MeSH terms